IL6 and Nephropathy: The nephropathy was successfully treated with tocilizumab, suggesting that IL-6 may cause diabetic nephropathy-like and/or arteriosclerotic-like nephropathy in patients with hypolipidemia, normal-range blood pressure, and normal glycemia.